Double FOYA Winners | How we’re delivering award-winning pharmaceutical facilities with Design to Value
She’s also aware that there’s a monetary opportunity here, on top of the current $14 trillion industry ecosystem.
Jaimie highlighted how the boundaries between industries are rapidly blurring, creating new opportunities for collaborative solutions.By linking sectors such as pharmaceuticals, digital design, energy, and process engineering, industries can share knowledge and resources, leading to faster and more impactful advancements.
He cited the development of a low-carbon Ventolin inhaler by GSK, a collaborative effort across multiple fields, as a case in point for what interconnected, interdisciplinary work can achieve.. 2.The urgency of accelerating industrialisation.Jaimie noted that although sustainable technologies are being developed at unprecedented speeds, their large-scale implementation lags behind.
He advocates for harnessing digital tools, prefabrication, and industrialised processes to expedite their roll-out.From designing flexible, modular manufacturing systems to implementing continuous production processes, these approaches can help industries achieve decarbonisation goals faster and more efficiently.. 3.
Accelerate Pharma: A platform for cross-sector collaboration.
Jaimie discussed Bryden Wood's role in convening leading pharmaceutical companies, such as GSK, Sanofi, Roche, and AstraZeneca, through the.Secondly, the expectations of the new cohorts of the workforce.
Those entering the workforce in the 2020s expect and demand that these commitments and activities are going on and this influences who they want to work for..Skills shortages were mentioned in the pre-event survey completed by participants.
Although not discussed in great detail, a number of key points were made about recruitment.Universities organised into traditional silos are not providing the skills required for the change ahead such as scientists with coding and equipment knowledge, or engineers with scientific understanding.